OPTA VIA, a coach-guided metabolic health program by Medifast, demonstrated significant clinical results in a 16-week randomized controlled trial. Participants lost 14% visceral fat and retained 98% of lean mass, verified by DXA body composition scans. Coach-supported clients lost 10 times more weight and 17 times more fat than self-directed participants, highlighting the importance of scientific measurement beyond scale weight. This research underscores the value of peer-reviewed evidence and high study completion rates in evaluating weight loss programs.
Uklon, a popular Ukrainian ride-hailing app owned by VEON Ltd., has launched Uklon Store, its first in-app marketplace, beginning with flower delivery services in Kyiv. This new feature allows users to order flowers from local florists and have them ...
US stock futures gained as investors monitored escalating US-Iran tensions and awaited key economic data including May's producer price index and weekly jobless claims. Despite regional instability from military strikes and airspace closures, major i...
Investa, a UK trading app, has introduced a pioneering rewards initiative granting over 3,000 active users stock options valued up to £1,000 based on the company's £10 million valuation. This program aims to share financial benefits with users who co...
A Russian national, Denis Obrezko, accused of aiding the Kremlin-linked hacking group Void Blizzard, was extradited from Thailand to the US. He faces charges related to cyber espionage targeting US and allied organizations, including at least 11 US c...
Wolters Kluwer repurchased 61,431 of its ordinary shares between June 4 and June 10, 2026, spending €3.9 million at an average price of €63.23 per share. This buyback is part of a larger €500 million program announced in February 2026, aimed at reduc...
